Sorry didnt fit page will try and fix

First 2 Last

Share
Profile

Follow
gmc

453 Posts.

12/12/16

09:30

Post #: 21263573
Share

Originally posted by gmc ↑

Just doing some back of the envelope figures on the Elko Coal asset potential. All very speculative and a few years away but if coaking coal remains at these prices all very possible.

I will use 2 million tpa of coal production in the equations

Will assume we have 200 million shares on issue and 1 billion $ debt from the cost of building the Elko mine.
Will assume a $100 million pa interest cost on the debt.
Will assume a $90 per tonne production cost as predicted in the FEC report.

Coaking coal price Annual production Income Production cost Interest payment Profit / Loss

US $100 2mill tonne $200 mill $180 mill $100 mill loss $80 mill
150 '' $300 mill '' '' profit $20 mill
200 '' $400 mill '' '' '' $120 mill
250 '' $500 mill '' '' '' $220 mill
300 '' $600 mill '' '' '' $320 mill
350 '' $700 mill '' '' '' $420 mill

So on a very conservative PE of 5 @ coal price of $150 per tonne you get Elko valued at $100 million which equates to around 50c per share.

@ $200 a tonne you get the Coal asset valued @ $600 million which equates to about $3 per share.
At the current Coal price of US $300 per tonne we have a valuation around $ 1.6 billion which equates to $8 per share.
I know these figures seem crazy at the moment but Im just trying to point out the potential PAK has and thats not including Imagines potential which is impossible to put a price on.
Happy to be shot down in flames.
A lot needs to go our way but really if the coaking coal price can stay above $150 it seems like a no brainer.

GLTA

gmc

Expand

Sorry didnt fit page will try and fix

PAK Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

PL3

Patagonia looks to raise $2.15M for South American exploration and development

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

There are more pages in this discussion • 10 more messages in this thread...

First 2 Last

Add AVM (ASX) to my watchlist

(20min delay)
Last 2.6¢		Change 0.000(0.00%)		Mkt cap ! $3.520M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	81000	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	1065748	4

View Market Depth

No.	Vol.	Price($)
2	81000	0.024
1	43478	0.023
1	500000	0.022
2	297615	0.021
4	324495	0.020

Price($)	Vol.	No.
0.026	1065748	4
0.027	300000	1
0.029	45000	1
0.030	42637	1
0.031	50000	1

Last trade - 16.12pm 09/07/2024 (20 minute delay)

AVM (ASX) Chart

Day chart unavailable

Sorry didnt fit page will try and fix

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sorry didnt fit page will try and fix

Top Stories

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News